ID: ALA4635021

Max Phase: Preclinical

Molecular Formula: C28H27F4N3O3

Molecular Weight: 529.53

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1Nc1ccccc1C(=O)N1CCC(N(C)C(=O)c2ccc(F)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C28H27F4N3O3/c1-34(26(36)20-12-11-18(29)17-22(20)28(30,31)32)19-13-15-35(16-14-19)27(37)21-7-3-4-8-23(21)33-24-9-5-6-10-25(24)38-2/h3-12,17,19,33H,13-16H2,1-2H3

Standard InChI Key:  SUGACIRRQDVQFQ-UHFFFAOYSA-N

Associated Targets(Human)

Smoothened homolog 1371 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Daoy 570 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A2058 690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 529.53Molecular Weight (Monoisotopic): 529.1989AlogP: 5.97#Rotatable Bonds: 6
Polar Surface Area: 61.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.98CX LogD: 5.98
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.40Np Likeness Score: -1.48

References

1. Ji D, Zhang W, Xu Y, Zhang JJ..  (2020)  Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.,  28  (6): [PMID:32063403] [10.1016/j.bmc.2020.115354]

Source